Global Markets for Neglected Tropical Disease Treatments

Global Markets for Neglected Tropical Disease Treatments

  • BCC Research
  • June 2017
  • Pharmaceutical
  • 161 pages

Report Description

1
1


The global market for neglected tropical diseases should reach $2.6 billion by 2021 from $1.4 billion in 2016 at a compound annual growth rate (CAGR) of 14.1%, from 2016 to 2021.
The market for malaria treatments is expected to grow from $513.5 million in 2016 to $757.9 million in 2021 at a CAGR of 8.1% for the period 2016-2021.
The dengue (vaccine) segment of the neglected tropical diseases market is expected to grow from $299.4 million in 2016 to $1.3 billion in 2021 at a CAGR of 34.8% for the period 2016-2021.

##img_0##

Have query on this report?

Make an Enquiry

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 4 Market Overview
Chapter 5 Market Influencing Factors
Chapter 6 Research and Development
Chapter 7 Patent Review
Chapter 8 Company Profiles
Total Addressable Market
Malaria
Malaria - Market Share by Geography
Leishmaniasis
Leishmaniasis - Market Share by Geography
Schistosomiasis
Schistosomiasis - Market Share by Geography
Lymphatic Filariasis
Lymphatic Filariasis - Market Share by Geography
Chagas Disease
Chagas Disease - Market Share by Geography
African Trypanosomiasis
Dengue
Dengue - Market Share by Geography
Ebola
Zika
Zika - Market Share by Geography
Donations by Pharmaceutical Companies: Access to Medicines
Market Drivers
Market Deterrents
Malaria
Leishmaniasis
Lymphatic Filariasis
Chagas Disease
African Trypanosomiasis
Dengue
Ebola
Zika
Malaria
Leishmaniasis
Schistosomiasis
Lymphatic Filariasis
Chagas Disease
African Trypanosomiasis
Dengue
Ebola
Zika
Unmet Needs
Malaria
Leishmaniasis
Schistosomiasis
Lymphatic Filariasis
Chagas Disease
African Trypanosomiasis
Dengue
Ebola
Zika
Malaria
Clinical Trials in Malaria
Leishmaniasis
Clinical Trials in Leishmaniasis
Schistosomiasis
Clinical Trials in Schistosomiasis
Lymphatic Filariasis
Clinical Trials in Lymphatic Filariasis
Chagas Disease
African Trypanosomiasis
Dengue
Ebola
Zika
Clinical Trials in Chagas Disease
Clinical Trials in African Trypanosomiasis
Clinical Trials in Dengue
Clinical Trials in Ebola
Clinical Trials in Zika
Malaria
Patent Review by Assignee
Patent Review by Year
Patent Review by Country
Patent Review by Type
Leishmaniasis
Patent Review by Assignee
Patent Review by Year
Patent Review by Country
Patent Review by Type
Schistosomiasis
Patent Review by Assignee
Patent Review by Year
Patent Review by Country
Patent Review by Type
Lymphatic Filariasis
Patent Review by Assignee
Patent Review by Year
Patent Review by Country
Patent Review by Type
Chagas Disease
Patent Review by Assignee
Patent Review by Year
Patent Review by Country
Patent Review by Type
African Trypanosomiasis
Patent Review by Assignee
Patent Review by Year
Patent Review by Country
Patent Review by Type
Dengue
Patent Review by Assignee
Patent Review by Year
Patent Review by Country
Patent Review by Type
Ebola
Patent Review by Assignee
Patent Review by Year
Patent Review by Country
Patent Review by Type
Zika
Patent Review by Assignee
Patent Review by Year
Patent Review by Country
Patent Review by Type
ANACOR PHARMACEUTICALS (NOW PFIZER)
BAYER
BUTANTAN
(DNDI) DRUGS FOR NEGLECTED DISEASES INITIATIVE
EISAI
GILEAD SCIENCES
GLAXOSMITHKLINE
MERCK
(MMV) MEDICINES FOR MALARIA VENTURE
NOVARTIS
THE PATH MALARIA VACCINE INITIATIVE
SABIN VACCINE INSTITUTE
SANOFI-AVENTIS/SANOFI PASTEUR
TAKEDA
Chapter 9 Appendix: Abbreviations
Research Portfolio and Alliances
Access to Medicines
Research Portfolio and Alliances
Research Portfolio and Alliances
Research Portfolio
Research Portfolio and Alliances
Access to Medicines
Research Portfolio and Alliances
Access to Medicines
Research Portfolio and Alliances
Research Portfolio and Alliances
Access to Medicines
Access to Medicines
Research Portfolio and Alliances
Research Portfolio and Alliances
Access to Medicines
Research Portfolio and Alliances
Research Portfolio and Alliances
Research Portfolio and Alliances
Access to Medicines:
Research Portfolio and Alliances
Research Portfolio and Alliances
Chapter 3 Disease Overview
Malaria
Incidence and Geographical Distribution
Etiology and Symptoms
Socioeconomic Burden
Current Method of Treatment
Leishmaniasis
Incidence and Geographical Distribution
Etiology and Symptoms
Socioeconomic Burden
Current Method of Treatment
Schistosomiasis
Incidence and Geographical Distribution
Etiology and Symptoms
Socioeconomic Burden
Current Method of Treatment
Lymphatic Filariasis
Incidence and Geographical Distribution
Etiology and Symptoms
Socioeconomic Burden
Current Method of Treatment
Chagas Disease
Incidence and Geographical Distribution
Etiology and Symptoms
Socioeconomic Burden
Current Method of Treatment
African Trypanosomiasis
Incidence and Geographical Distribution
Etiology and Symptoms
Socioeconomic Burden
Current Method of Treatment
Dengue
Incidence and Geographical Distribution
Etiology and Symptoms
Socioeconomic Burden
Current Method of Treatment
Ebola
Incidence and Geographical Distribution
Etiology and Symptoms
Socioeconomic Burden
Current Method of Treatment
Zika
Incidence and Geographical Distribution
Etiology and Symptoms
Socioeconomic Burden
Current Method of Treatment

Summary Table : Global Market for Neglected Tropical Diseases, by Indication, Through 2021
Table 1 : Key Trends in Neglected Tropical Diseases
Table 2 : Estimated Malaria Incidence (per 1,000 at Risk), 2000-2015
Table 3 : Suspected Malaria Cases, 2010-2015
Table 4 : Confirmed Malaria Cases, 2010-2015
Table 5 : Estimated Spending on Malaria Treatment in Sub-Saharan Africa, 2010-2014
Table 6 : WHO Guidelines for Treatment of Malaria
Table 7 : Number of Cases of CL in Select High Burden Countries, 2010-2014
Table 8 : Number of Cases of VL in Select High Burden Countries, 2010-2014
Table 9 : Incidence of CL and VL in High Burden Countries, 2014
Table 10 : Global Disease Burden of Leishmaniasis, 2015
Table 11 : WHO Guidelines for Treatment of Leishmaniasis
Table 12 : Number of People Treated Globally, 2010-2014
Table 13 : Global Disease Burden of Schistosomiasis, 2015
Table 14 : Global Disease Burden of Lymphatic Filariasis, 2015
Table 15 : Prevalence and Incidence (Number) of Chagas Disease, 2015
Table 16 : Global Disease Burden of Chagas Disease, 2015
Table 17 : Prevalence and Incidence (Number) of Chagas Disease, 2015
Table 18 : Global Disease Burden of African Trypanosomiasis, 2015
Table 19 : Prevalence and Incidence (Number) of Dengue Cases, 2015
Table 20 : Reported Cases and Deaths in Ebola Outbreaks, 2007-2016
Table 21 : Zika Burden, 2015-2016
Table 22 : Global Addressable Market for Neglected Tropical Diseases, by Indication, Through 2021
Table 23 : Global Addressable Market for Malaria, by Region, Through 2021
Table 24 : Global Addressable Market for Leishmaniasis, by Region, Through 2021
Table 25 : Global Addressable Market for Schistosomiasis, by Region, Through 2021
Table 26 : Global Addressable Market for Lymphatic Filariasis, by Region, Through 2021
Table 27 : Global Addressable Market for Chagas Disease, by Geography, Through 2021
Table 28 : Global Addressable Market for Dengue, by Region, Through 2021
Table 29 : Global Addressable Market for Zika, by Region, Through 2021
Table 30 : Drug Donation Commitments, by WHO
Table 31 : Malaria Development Pipeline and Recent Launches
Table 32 : Leishmaniasis Development Pipeline and Recent Launches
Table 33 : Schistosomiasis Development Pipeline and Recent Launches
Table 34 : Lymphatic Filariasis Development Pipeline and Recent Launches
Table 35 : Chagas Disease Development Pipeline and Recent Launches
Table 36 : African Trypanosomiasis Development Pipeline and Recent Launches
Table 37 : Dengue Development Pipeline and Recent Launches
Table 38 : Ebola Development Pipeline and Recent Launches
Table 39 : Zika Development Pipeline and Recent Launches
Table 40 : Number of Patent Applications, Malaria, by Assignee
Table 41 : Number of Patent Applications, Malaria, by Year, 2010-2015
Table 42 : Number of Patent Applications, Malaria, by Country
Table 43 : Number of Patent Applications, Malaria, by Type
Table 44 : Number of Patent Applications, Leishmaniasis, by Assignee
Table 45 : Number of Patent Applications, Leishmaniasis, by Year, 2010-2015
Table 46 : Number of Patent Applications, Leishmaniasis, by Country
Table 47 : Number of Patent Applications, Leishmaniasis, by Type
Table 48 : Number of Patent Applications, Schistosomiasis, by Assignee
Table 49 : Number of Patent Applications, Schistosomiasis, by Year, 2010-2015
Table 50 : Number of Patent Applications, Schistosomiasis, by Country
Table 51 : Number of Patent Applications, Schistosomiasis, by Type
Table 52 : Number of Patent Applications, Lymphatic Filariasis, by Assignee
Table 53 : Number of Patent Applications, Lymphatic Filariasis, by Year, 2010-2015
Table 54 : Number of Patent Applications, Lymphatic Filariasis, by Country
Table 55 : Number of Patent Applications, Lymphatic Filariasis, by Type
Table 56 : Number of Patent Applications, Chagas Disease, by Assignee
Table 57 : Number of Patent Applications, Chagas Disease, by Year, 2010-2015
Table 58 : Number of Patent Applications, Chagas Disease, by Country
Table 59 : Number of Patent Applications, Chagas Disease, by Type
Table 60 : Number of Patent Applications, African Trypanosomiasis, by Assignee
Table 61 : Number of Patent Applications, African Trypanosomiasis, by Year, 2010-2015
Table 62 : Number of Patent Applications, African Trypanosomiasis, by Country
Table 63 : Number of Patent Applications, African Trypanosomiasis, by Type
Table 64 : Number of Patent Applications, Dengue, by Assignee
Table 65 : Number of Patent Applications, Dengue, by Year, 2010-2015
Table 66 : Number of Patent Applications, Dengue, by Country
Table 67 : Number of Patent Applications, Dengue, by Type
Table 68 : Number of Patent Applications, Ebola, by Assignee
Table 69 : Number of Patent Applications, Ebola, by Year, 2010-2016
Table 70 : Number of Patent Applications, Ebola, by Country
Table 71 : Number of Patent Applications, Ebola, by Type
Table 72 : Number of Patent Applications, Zika, by Assignee
Table 73 : Number of Patent Applications, Zika, by Year, 2010-2016
Table 74 : Number of Patent Applications, Zika, by Country
Table 75 : Number of Patent Applications, Zika, by Type
Table 76 : Abbreviations Used in Neglected Tropical Diseases Landscape
Table 77 : Glossary of Terms Used in Neglected Tropical Diseases Landscape
Table 78 : Report Sources

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074